LIQUIDIA TECHNOLOGIES, INC. Patent Applications Pending
7 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2026-03-26: Application 19629870; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Notice of Allowance Mailed -- Application Received in Office of Publications.
- 2026-03-26: Application 19629817; Invention Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status Final Rejection Mailed.
- 2026-01-23: Application PCTUS2026012324; Invention BOOSTER THERAPY FOR TREATING OR PREVENTING EXACERBATIONS OF PULMONARY HYPERTENSION SYMPTOMS; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status PCT - International Search Report Mailed to IB.
- 2025-11-14: Application PCTUS2025055483; Invention COMBINATION THERAPY FOR THE TREATMENT OF PULMONARY HYPERTENSION; Applicant LIQUIDIA TECHNOLOGIES, INC.; Status PCT - International Search Report Mailed to IB.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | 19629870 | Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension | LIQUIDIA TECHNOLOGIES, INC. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20260216210A1 | Robert Frank Roscigno Brian T. Farrer Jacob J. Sprague Benjamin Maynor | United States United States United States United States | RONEY, CELESTE A |
| 2026-03-26 | 19629817 | Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension | LIQUIDIA TECHNOLOGIES, INC. | Final Rejection Mailed | US20260216209A1 | Robert Frank Roscigno Brian T. Farrer Jacob J. Sprague Benjamin Maynor | United States United States United States United States | RONEY, CELESTE A |
| 2026-01-23 | PCTUS2026012324 | BOOSTER THERAPY FOR TREATING OR PREVENTING EXACERBATIONS OF PULMONARY HYPERTENSION SYMPTOMS | LIQUIDIA TECHNOLOGIES, INC. | PCT - International Search Report Mailed to IB | RAJEEV SAGGAR | United States | KIM, HARRY CHONG HYUN | |
| 2025-11-14 | PCTUS2025055483 | COMBINATION THERAPY FOR THE TREATMENT OF PULMONARY HYPERTENSION | LIQUIDIA TECHNOLOGIES, INC. | PCT - International Search Report Mailed to IB | RAJEEV SAGGAR | United States | KIM, HARRY CHONG HYUN | |
| 2025-07-07 | 19261256 | Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension | LIQUIDIA TECHNOLOGIES, INC. | Docketed New Case - Ready for Examination | US20250332175A1 | Robert Frank Roscigno Brian T. Farrer Jacob J. Sprague Benjamin Maynor | United States United States United States United States | CENTRAL, DOCKET |
| 2025-01-24 | 63749296 | Booster Therapy for Treating or Preventing Exacerbations of Pulmonary Hypertension Symptoms | LIQUIDIA TECHNOLOGIES, INC. | Provisional Application Expired | Rajeev Saggar | United States | ||
| 2024-11-15 | 63721016 | Combination Therapy for the Treatment of Pulmonary Hypertension | LIQUIDIA TECHNOLOGIES, INC. | Provisional Application Expired | Rajeev Saggar | United States |